Atlas Trials

Evaluation of the Safety and Efficacy of the Second Dose of Tranexamic Acid

Clinical trial NCT03846973 · COMPLETED

Trial details

NCT number
NCT03846973
Sponsor
Hamad Medical Corporation
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Tranexamic Acid
Start date
2018-12-02
Primary completion
2021-01-31
Enrollment
220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.